Question:
Specific case of drug embedding in insoluble excipients (typically in a polymer) in order to achieve extended release.
Answer:
matrix formulation
Related Questions & One-Liners
- Insertion or grafting of a biological, living, inert, or radioactive material into the body.
- Small sterile usually polymeric matrices, pellets, or particles for insertion or implanting into the body by surgical means or by injection to help achieve sustained release.
- Emulsions in which the dispersed droplets are in the micron-size range.
- Number that expresses the reduction in the numbers of a microorganism, brought about by a sterilizaion process.
- Formation of microparticles encapsulating a drug.
- Reversible formation of association colloids from surfactants in nonpolar solvents leads to aggregates termed inverted (or inverse, reverse, or reversed) micelles.
- A Solid spherical particles of micron-size range, used as matrix dosage forms.
- Artificial spherical lipid bilayer droplet formed mainly from phospholipids having a core of water phase, small enough to form a relatively stable dispersion in aqueous media and with potential use in drug delivery.
- Concentration of a drug that must be achieved in the plasma before any desired therapeutic or pharmacological effect can be obtained.
- Initial, typically larger than the maintenance dose of a drug given to a patient at the start of pharmacotherapy.
- Lowest concentration of an antibacterial drug necessary to inhibit the growth of a microorganism.
- Tablet, which does not contain a disintegrant and which is sucked to dissolve in the mouth to produce either a local (e.g., antiseptic) or systemic (e.g., vitamins) effect.
- Release of a drug from a dosage form that it is not immediate
- Used as processing aid in tablet and capsule manufacturing, to facilitate the movement of the formulation into the dye and punch and to reduce the energy of compression.
